In 2022, the Chinese pharmaceutical giant Jiangsu Hengrui Pharmaceuticals spent more than 6.3 billion yuan on research and development, representing almost 30 percent of its overall operating income. As the leading developer of oncology medicine, the company's R&D spending increased by more than 400 percent since 2016.
Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shanghai Stock Exchange. (April 22, 2023). Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022 [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange. "Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022." Chart. April 22, 2023. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange. (2023). Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022. Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange. "Share of Research and Development Expenditure in Overall Operating Revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022." Statista, Statista Inc., 22 Apr 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange, Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/ (last visited September 20, 2024)
Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2022 [Graph], Shanghai Stock Exchange, April 22, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/